Raymond F. Suckow

High dose D-serine in the treatment of schizophrenia

Joshua T. Kantrowitz, Anil K. Malhotra, Barbara A. Cornblatt et al. · Schizophrenia Research · 2010 · 247 citations · Full text

Medicine, Pharmacology, Psychiatry +12

Relationship of resting brain hyperconnectivity and schizophrenia-like symptoms produced by the NMDA receptor antagonist ketamine in humans

Naomi Driesen, Gregory McCarthy, Zubin Bhagwagar et al. · Molecular Psychiatry · 2013 · 232 citations · Full text

Medicine, Neuroscience, Psychiatry +16

Interactive effects of subanesthetic ketamine and subhypnotic lorazepam in humans

John Krystal, Laurence P. Karper, Alexandre Bennett et al. · Psychopharmacology · 1998 · 185 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +14

The Impact of NMDA Receptor Blockade on Human Working Memory-Related Prefrontal Function and Connectivity

Naomi Driesen, Gregory McCarthy, Zubin Bhagwagar et al. · Neuropsychopharmacology · 2013 · 154 citations · Full text

Life Sciences, Neurobiology, Neuroscience +14

A pilot in vivo proton magnetic resonance spectroscopy study of amino acid neurotransmitter response to ketamine treatment of major depressive disorder

Matthew S. Milak, Carol J. Proper, Stephanie Mulhern et al. · Molecular Psychiatry · 2015 · 142 citations

Life Sciences, Neuroscience, Pharmacology +14